A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4.
Fujioka M, Akiyama T, Hosoya M, Kikuchi K, Fujiki Y, Saito Y, Yoshihama K, Ozawa H, Tsukada K, Nishio SY, Usami SI, Matsunaga T, Hasegawa T, Sato Y, Ogawa K.
Fujioka M, et al. Among authors: ozawa h.
Medicine (Baltimore). 2020 May;99(19):e19763. doi: 10.1097/MD.0000000000019763.
Medicine (Baltimore). 2020.
PMID: 32384426
Free PMC article.
Clinical Trial.